Market revenue in 2020 | USD 125.3 billion |
Market revenue in 2028 | USD 423.2 billion |
Growth rate | 16.4% (CAGR from 2020 to 2028) |
Largest segment | Detection kits |
Fastest growing segment | Detection Kits |
Historical data covered | 2018 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2028 |
Quantitative units | Revenue in USD billion |
Market segmentation | Purification Kits, Amplification Kits, Detection Kits, Isolation Kits |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, New England Biolabs, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, LGC Group, Toyobo Co Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology reagents & kits market will help companies and investors design strategic landscapes.
Detection kits was the largest segment with a revenue share of 23.06% in 2020. Horizon Databook has segmented the North America biotechnology reagents & kits market based on purification kits, amplification kits, detection kits, isolation kits covering the revenue growth of each sub-segment from 2018 to 2028.
North America dominated the revenue share in 2021 owing to presence of major biotechnology & pharmaceutical companies offering reagents and kits for molecular biology, environmental biology, industrial biology, & other biotechnology fields.
The major pharma companies providing reagents and kits products, operating in this region are Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific Inc; Illumina; Promega Corporation; Becton, Dickinson and Company (BD); and Enzo Life Sciences, Inc. Moreover, several drug developers operating in this region are involved in strategic initiatives aiding market growth.
For instance, in December 2020, Lifespan Biosciences (LSBio) acquired Absolute antibody and its sister company Kerafast. This acquisition was expected to enable Absolute Antibody continue its growth, while delivering better quality recombinant antibody reagents & services.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America biotechnology reagents & kits market , including forecasts for subscribers. This continent databook contains high-level insights into North America biotechnology reagents & kits market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account